Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Nitrite

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Nitrite?

Nitrite is an investigational drug.

There have been 93 clinical trials for Nitrite. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2015.

The most common disease conditions in clinical trials are Hypertension, Heart Failure, and Diabetes Mellitus. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), University of Pittsburgh, and Aires Pharmaceuticals, Inc.

There are twenty-nine US patents protecting this investigational drug and six hundred and twenty-seven international patents.

Recent Clinical Trials for Nitrite
Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow RegulationUniversity of Wisconsin, MadisonPhase 1
Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis PatientsConselho Nacional de Desenvolvimento Científico e TecnológicoPhase 4
Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis PatientsUniversity of TaubatePhase 4

See all Nitrite clinical trials

Clinical Trial Summary for Nitrite

Top disease conditions for Nitrite
Top clinical trial sponsors for Nitrite

See all Nitrite clinical trials

US Patents for Nitrite

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nitrite   Start Trial Red blood cells loaded with S-nitrosothiol and uses therefor Duke University (Durham, NC)   Start Trial
Nitrite   Start Trial .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G. D. Searle & Co. (Chicago, IL)   Start Trial
Nitrite   Start Trial Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors G.D. Searle & Co. (Chicago, IL)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.